Functional RNA elements in the human genome
人类基因组中的功能性RNA元件
基本信息
- 批准号:9381421
- 负责人:
- 金额:$ 69.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAlternative SplicingAreaBindingBinding ProteinsBinding SitesBioinformaticsBiologyChromatinClustered Regularly Interspaced Short Palindromic RepeatsCouplingDNADNA Polymerase IIDNA-Directed RNA PolymeraseData SetDevelopmentDiseaseDissectionElementsEpigenetic ProcessEventFundingGene ExpressionGenesGenetic TranscriptionGenomic approachGenomicsGoalsGrantHuman GenomeIndividualLeadMammalian CellMass Spectrum AnalysisMessenger RNAMetabolismMethodologyMethodsMolecularNational Human Genome Research InstituteNuclear ExportNuclear PorePathologyPathway AnalysisPathway interactionsPatternPhasePolyadenylationPositioning AttributeProductivityProtein AnalysisProteinsPublicationsRANGAP1 geneRNARNA BindingRNA ProcessingRNA Recognition MotifRNA SplicingRNA analysisRNA-Binding ProteinsRNA-Protein InteractionReactionRecruitment ActivityRegulationRegulatory PathwayReproducibilityResearchRoleSequence HomologySeriesTestingTranscriptional RegulationUntranslated RNAZinc Fingerscomputerized toolseffective therapygenome-widegenomic RNAgenomic toolshuman diseaseinfancyinnovationinsightmRNA Precursormammalian genomenovelnovel strategiesnucleocytoplasmic transportprotein profilingprotein protein interactionscreeningtechnological innovationtranscription factortranscriptometreatment strategy
项目摘要
Project Summary
This proposal seeks competitive renewal of a multi-PI project (Fu and Yeo), which aims to use global
approaches to elucidate the regulatory principles of RNA binding proteins (RBPs) in mammalian genomes.
Built upon our accomplishments in the past funding cycle, we propose to leverage the powerful experimental
and computational tools we have developed to pursue four specific aims. In Aim 1, we will couple gain- and
lost-of-function multi-target screens to deduce regulatory pathways at both splicing and polyadenylation levels.
We will focus on determining the specific function of different RNA polymerase II (Pol II) subunits, rather than
by the Pol II CTD alone, in the recruitment of RNA processing machineries for co-transcriptional RNA
processing. In Aim 2, we will develop a general strategy for systematic identification of chromatin-associated
RBPs to determine direct contribution of some RBPs to transcription and co-transcriptional RNA processing
reactions. We will concentrate our efforts in dissecting a potential new pathway in epigenetic control of
alternative splicing as well as broader roles of specific RBPs in direct transcriptional control. In Aim 3, we will
use a novel strategy for identification and characterization of non-canonical RBPs. Focusing on a large
number of newly identified finger zinc (Znf) proteins, we propose to determine their roles in binding to both
DNA and RNA and deduce their transcriptome-wide interactions with RNA. We also propose to pursue a
specific paradigm in this aim on a newly identified RBP known to associate with the nuclear pore to determine
its role in selective mRNA nuclear export, which is pertinent to an ALS-regulated disease pathology.
Combined, we believe that this comprehensive, interconnected, and hypothesis-driven research plan will
greatly advance our understanding of regulated RNA processing and associated disease mechanisms.
项目摘要
该提案寻求竞争性更新的多PI项目(FU和YEO),该项目旨在使用全球
阐明哺乳动物基因组中RNA结合蛋白(RBP)的调节原理的方法。
基于我们在过去的资金周期中的成就,我们建议利用强大的实验性
和计算工具我们已经开发了四个特定目标。在AIM 1中,我们将夫妇获得并获得
失去功能多目标屏幕,无法在剪接和聚腺苷酸水平上推断调节途径。
我们将专注于确定不同RNA聚合酶II(POL II)亚基的特定功能,而不是
仅由Pol II CTD,在招募共同转录RNA的RNA加工机器中
加工。在AIM 2中,我们将制定一种系统识别染色质相关的一般策略
RBP确定某些RBP对转录和共转录RNA处理的直接贡献
反应。我们将集中精力在剖析潜在的新途径中的表观遗传控制中
特定RBP在直接转录控制中的替代剪接以及更广泛的作用。在AIM 3中,我们将
使用一种新的策略来识别和表征非规范的RBP。专注于大型
新鉴定的手指锌(ZNF)蛋白的数量,我们建议确定它们在与两者结合的作用
DNA和RNA并推导其与RNA的全转录组相互作用。我们还建议追求
在此目标中,特定的范式以新近确定的RBP与核孔相关以确定
它在选择性mRNA核输出中的作用,这与ALS调节的疾病病理有关。
结合在一起,我们认为这个全面,相互联系和假设驱动的研究计划将
大大提高了我们对受调节的RNA处理和相关疾病机制的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIANG-DONG FU其他文献
XIANG-DONG FU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIANG-DONG FU', 18)}}的其他基金
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8734415 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9081584 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8915157 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8647698 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9310249 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
FUNCTION AND REGULATION OF THE HUMAN SPLICING FACTOR SC35
人类剪接因子 SC35 的功能和调控
- 批准号:
7845881 - 财政年份:2009
- 资助金额:
$ 69.75万 - 项目类别:
相似国自然基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
- 批准号:82372743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
MEK/ERK通路对Bim选择性剪接的调节及其在胃癌细胞对化疗敏感性中作用
- 批准号:81071809
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
- 批准号:30971223
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
m6A-suite: an informatics pipeline and resource for elucidating roles of m6A epitranscriptome in cancer
m6A-suite:用于阐明 m6A 表观转录组在癌症中的作用的信息学管道和资源
- 批准号:
10645584 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Feedback regulation of cannabinoid receptor trafficking and signaling
大麻素受体运输和信号传导的反馈调节
- 批准号:
10312886 - 财政年份:2022
- 资助金额:
$ 69.75万 - 项目类别: